AEVA vs. MASS, CVGI, MAPS, GOEV, HBIO, INVZ, CPS, MPAA, CAAS, and SUP
Should you be buying Aeva Technologies stock or one of its competitors? The main competitors of Aeva Technologies include 908 Devices (MASS), Commercial Vehicle Group (CVGI), WM Technology (MAPS), Canoo (GOEV), Harvard Bioscience (HBIO), Innoviz Technologies (INVZ), Cooper-Standard (CPS), Motorcar Parts of America (MPAA), China Automotive Systems (CAAS), and Superior Industries International (SUP).
908 Devices (NASDAQ:MASS) and Aeva Technologies (NYSE:AEVA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, community ranking, analyst recommendations and valuation.
Aeva Technologies received 7 more outperform votes than 908 Devices when rated by MarketBeat users. However, 61.54% of users gave 908 Devices an outperform vote while only 50.00% of users gave Aeva Technologies an outperform vote.
In the previous week, 908 Devices had 10 more articles in the media than Aeva Technologies. MarketBeat recorded 15 mentions for 908 Devices and 5 mentions for Aeva Technologies. Aeva Technologies' average media sentiment score of 1.27 beat 908 Devices' score of 0.37 indicating that 908 Devices is being referred to more favorably in the media.
908 Devices has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Aeva Technologies has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500.
908 Devices has higher revenue and earnings than Aeva Technologies. 908 Devices is trading at a lower price-to-earnings ratio than Aeva Technologies, indicating that it is currently the more affordable of the two stocks.
908 Devices currently has a consensus price target of $14.00, indicating a potential upside of 93.91%. Aeva Technologies has a consensus price target of $10.92, indicating a potential upside of 194.34%. Given 908 Devices' higher probable upside, analysts clearly believe Aeva Technologies is more favorable than 908 Devices.
908 Devices has a net margin of -68.57% compared to 908 Devices' net margin of -2,835.99%. Aeva Technologies' return on equity of -20.87% beat 908 Devices' return on equity.
88.1% of 908 Devices shares are owned by institutional investors. Comparatively, 62.9% of Aeva Technologies shares are owned by institutional investors. 27.8% of 908 Devices shares are owned by company insiders. Comparatively, 34.6% of Aeva Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
908 Devices beats Aeva Technologies on 11 of the 18 factors compared between the two stocks.
Get Aeva Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for AEVA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AEVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aeva Technologies Competitors List
Related Companies and Tools
